Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903482 · ClinicalTrials.gov registry record
Gastric Volume in Patients on GLP-1 Medications
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 70
- Enrollment target
NCT05903482: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT05903482 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05903482 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Evaluating gastric volume in patients on GLP-1 RA medications
Primary Outcome
A non-invasive, ultrasound will be performed to assess gastric volume. A second investigator not performing the ultrasound and blinded to whether the subject is taking a GLP-1 RA medication and whether the patient has diabetes and/or obesity will then assess the ultrasound images qualitatively for gastric contents (empty, clear liquids, solids) and quantitatively for gastric fluid volume if applicable.
Interventions
- OTHER None - observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2024-12-31 |
What the finished NCT05903482 record still lists
NCT05903482 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which None - observational is the first listed.
NCT05903482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05903482 about?
NCT05903482 is a clinical study titled "Gastric Volume in Patients on GLP-1 Medications". Evaluating gastric volume in patients on GLP-1 RA medications
What is the current status of trial NCT05903482?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2023-06-06. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05903482?
The interventions under investigation include: None - observational (OTHER).
Who is sponsoring clinical trial NCT05903482?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI